Cargando…

ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I

OBJECTIVE: To perform anthropometric and dietary evaluation of patients with glycogenosis type Ia and Ib. METHODS: This cross-sectional study is composed of a sample of 11 patients with glycogenosis divided into two subgroups according to the classification of glycogenosis (type Ia=5 and type Ib=6),...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorge, Natália Bauab, de Tommaso, Adriana Maria Alves, Hessel, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade de Pediatria de São Paulo 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875543/
https://www.ncbi.nlm.nih.gov/pubmed/33566881
http://dx.doi.org/10.1590/1984-0462/2021/39/2020046
_version_ 1783649787339341824
author Jorge, Natália Bauab
de Tommaso, Adriana Maria Alves
Hessel, Gabriel
author_facet Jorge, Natália Bauab
de Tommaso, Adriana Maria Alves
Hessel, Gabriel
author_sort Jorge, Natália Bauab
collection PubMed
description OBJECTIVE: To perform anthropometric and dietary evaluation of patients with glycogenosis type Ia and Ib. METHODS: This cross-sectional study is composed of a sample of 11 patients with glycogenosis divided into two subgroups according to the classification of glycogenosis (type Ia=5 and type Ib=6), aged between 4 and 20 years. The analyzed anthropometric variables were weight, height, body mass index, and measures of lean and fat body mass, which were compared with reference values. For dietary assessment, a food frequency questionnaire was used to calculate energy and macronutrients intake as well as the amount of raw cornstarch consumed. Mann-Whitney U test and Fisher’s exact test were performed, considering a significance level of 5%. RESULTS: Patients ingested raw cornstarch in the amount of 0.49 to 1.34 g/kg/dose at a frequency of six times a day, which is lower than recommended (1.75-2.50 g/kg/dose, four times a day). The amount of energy intake was, on average, 50% higher than energy requirements; however, carbohydrate intake was below the adequacy percentage in 5/11 patients. Short stature was found in 4/10 patients; obesity, in 3/11; and muscle mass deficit, in 7/11. There were no statistical differences between the subgroups. CONCLUSIONS: In patients with glycogenosis type I, there was deficit in growth and muscle mass, but no differences were found between the subgroups (Ia and Ib). Although the diet did not exceed the adequacy of carbohydrates, about 1/3 of the patients presented obesity, probably due to higher energy intake.
format Online
Article
Text
id pubmed-7875543
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade de Pediatria de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-78755432021-02-19 ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I Jorge, Natália Bauab de Tommaso, Adriana Maria Alves Hessel, Gabriel Rev Paul Pediatr Original Article OBJECTIVE: To perform anthropometric and dietary evaluation of patients with glycogenosis type Ia and Ib. METHODS: This cross-sectional study is composed of a sample of 11 patients with glycogenosis divided into two subgroups according to the classification of glycogenosis (type Ia=5 and type Ib=6), aged between 4 and 20 years. The analyzed anthropometric variables were weight, height, body mass index, and measures of lean and fat body mass, which were compared with reference values. For dietary assessment, a food frequency questionnaire was used to calculate energy and macronutrients intake as well as the amount of raw cornstarch consumed. Mann-Whitney U test and Fisher’s exact test were performed, considering a significance level of 5%. RESULTS: Patients ingested raw cornstarch in the amount of 0.49 to 1.34 g/kg/dose at a frequency of six times a day, which is lower than recommended (1.75-2.50 g/kg/dose, four times a day). The amount of energy intake was, on average, 50% higher than energy requirements; however, carbohydrate intake was below the adequacy percentage in 5/11 patients. Short stature was found in 4/10 patients; obesity, in 3/11; and muscle mass deficit, in 7/11. There were no statistical differences between the subgroups. CONCLUSIONS: In patients with glycogenosis type I, there was deficit in growth and muscle mass, but no differences were found between the subgroups (Ia and Ib). Although the diet did not exceed the adequacy of carbohydrates, about 1/3 of the patients presented obesity, probably due to higher energy intake. Sociedade de Pediatria de São Paulo 2021-02-05 /pmc/articles/PMC7875543/ /pubmed/33566881 http://dx.doi.org/10.1590/1984-0462/2021/39/2020046 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
Jorge, Natália Bauab
de Tommaso, Adriana Maria Alves
Hessel, Gabriel
ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I
title ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I
title_full ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I
title_fullStr ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I
title_full_unstemmed ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I
title_short ANTHROPOMETRIC AND DIETARY ASSESSMENT OF PATIENTS WITH GLYCOGENOSIS TYPE I
title_sort anthropometric and dietary assessment of patients with glycogenosis type i
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875543/
https://www.ncbi.nlm.nih.gov/pubmed/33566881
http://dx.doi.org/10.1590/1984-0462/2021/39/2020046
work_keys_str_mv AT jorgenataliabauab anthropometricanddietaryassessmentofpatientswithglycogenosistypei
AT detommasoadrianamariaalves anthropometricanddietaryassessmentofpatientswithglycogenosistypei
AT hesselgabriel anthropometricanddietaryassessmentofpatientswithglycogenosistypei